See more : Yankuang Energy Group Company Limited (YZCAY) Income Statement Analysis – Financial Results
Complete financial analysis of Medistim ASA (0OCD.L) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Medistim ASA, a leading company in the Medical – Equipment & Services industry within the Healthcare sector.
- Banco do Brasil S.A. (BDORY) Income Statement Analysis – Financial Results
- Société Générale Société anonyme (GLE.PA) Income Statement Analysis – Financial Results
- European Metals Holdings Limited (EMH.AX) Income Statement Analysis – Financial Results
- Magnum Ventures Limited (MAGNUM.BO) Income Statement Analysis – Financial Results
- Sigma Lithium Corporation (SGML) Income Statement Analysis – Financial Results
Medistim ASA (0OCD.L)
About Medistim ASA
Medistim ASA develops, produces, services, leases, and distributes medical devices for cardio-vascular surgery in the United States, Europe, Asia, and internationally. It offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and transit TTFM in a single system for vascular surgery; and imaging probes for intraoperative use. The company also provides various flow probes, such as QuickFit TTFM probes to accurately measure blood volume flow intraoperatively in various range of surgical applications; Vascular TTFM probes for enhancing surgical outcomes; and doppler probes that are used on the surface of the heart/vessel to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, it distributes and sells third party medical equipment. The company was incorporated in 1984 and is headquartered in Oslo, Norway.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 521.11M | 486.26M | 417.82M | 356.21M | 356.91M | 323.01M | 296.05M | 262.67M | 249.97M | 214.25M | 190.33M | 181.97M |
| Cost of Revenue | 296.41M | 268.64M | 247.64M | 210.55M | 218.73M | 79.38M | 72.78M | 64.96M | 64.65M | 55.57M | 49.19M | 49.44M |
| Gross Profit | 224.70M | 217.62M | 170.18M | 145.66M | 138.18M | 243.63M | 223.27M | 197.72M | 185.32M | 158.68M | 141.15M | 132.53M |
| Gross Profit Ratio | 43.12% | 44.75% | 40.73% | 40.89% | 38.72% | 75.42% | 75.42% | 75.27% | 74.14% | 74.06% | 74.16% | 72.83% |
| Research & Development | 29.00M | 13.90M | 14.50M | 14.60M | 7.80M | 12.39M | 14.14M | 13.32M | 10.09M | 7.15M | 7.15M | 8.42M |
| General & Administrative | 63.12M | 130.60M | 121.10M | 106.59M | 109.72M | 94.53M | 94.91M | 86.50M | 76.43M | 67.10M | 59.90M | 58.44M |
| Selling & Marketing | 6.39M | 5.91M | 2.92M | 1.80M | 6.37M | 5.51M | 4.39M | 4.22M | 3.31M | 4.28M | 4.16M | 4.04M |
| SG&A | 69.51M | 68.15M | 48.86M | 42.50M | 47.43M | 100.05M | 99.29M | 90.73M | 79.74M | 71.39M | 64.06M | 62.48M |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 6.81M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 98.51M | 82.05M | 63.36M | 57.10M | 48.42M | 168.73M | 156.23M | 143.94M | 129.34M | 113.23M | 103.46M | 91.13M |
| Cost & Expenses | 394.92M | 350.69M | 311.00M | 267.65M | 267.15M | 248.11M | 229.01M | 208.90M | 193.99M | 168.80M | 152.65M | 140.57M |
| Interest Income | 17.12M | 920.00K | 16.00K | 5.00K | 184.00K | 426.00K | 427.00K | 249.00K | 333.00K | 561.00K | 196.00K | 249.00K |
| Interest Expense | 13.35M | 385.00K | 590.00K | 416.00K | 686.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 23.66M | 16.20M | 16.27M | 9.57M | 12.36M | 12.36M | 5.49M | 4.11M | 4.76M | 4.21M | 3.65M | 2.86M |
| EBITDA | 146.72M | 157.45M | 132.03M | 108.28M | 102.13M | 86.34M | 70.96M | 60.46M | 57.76M | 47.57M | 39.26M | 47.93M |
| EBITDA Ratio | 28.76% | 31.45% | 29.72% | 29.42% | 30.20% | 26.73% | 23.97% | 23.02% | 23.11% | 22.20% | 20.62% | 19.06% |
| Operating Income | 126.19M | 135.58M | 106.82M | 88.56M | 89.77M | 73.98M | 65.47M | 56.36M | 53.01M | 43.36M | 35.61M | 31.83M |
| Operating Income Ratio | 24.22% | 27.88% | 25.57% | 24.86% | 25.15% | 22.90% | 22.11% | 21.45% | 21.20% | 20.24% | 18.71% | 17.49% |
| Total Other Income/Expenses | 3.77M | 10.47M | 7.25M | -3.88M | 1.28M | 502.00K | -481.00K | -2.83M | -2.21M | 1.53M | 2.53M | 9.82M |
| Income Before Tax | 135.21M | 146.05M | 114.07M | 91.61M | 91.04M | 74.48M | 66.61M | 53.53M | 55.65M | 44.89M | 37.49M | 41.65M |
| Income Before Tax Ratio | 25.95% | 30.04% | 27.30% | 25.72% | 25.51% | 23.06% | 22.50% | 20.38% | 22.26% | 20.95% | 19.70% | 22.89% |
| Income Tax Expense | 31.39M | 32.08M | 23.17M | 22.22M | 20.74M | 17.42M | 19.04M | 14.43M | 15.22M | 13.65M | 10.95M | 11.41M |
| Net Income | 103.82M | 113.97M | 90.90M | 69.39M | 70.31M | 57.06M | 47.57M | 39.10M | 40.42M | 31.25M | 26.54M | 30.25M |
| Net Income Ratio | 19.92% | 23.44% | 21.76% | 19.48% | 19.70% | 17.66% | 16.07% | 14.88% | 16.17% | 14.58% | 13.94% | 16.62% |
| EPS | 5.68 | 6.25 | 4.99 | 3.81 | 3.87 | 3.13 | 2.62 | 2.15 | 2.23 | 1.73 | 1.47 | 1.66 |
| EPS Diluted | 5.67 | 6.24 | 4.98 | 3.80 | 3.86 | 3.13 | 2.62 | 2.15 | 2.23 | 1.73 | 1.47 | 1.66 |
| Weighted Avg Shares Out | 18.27M | 18.25M | 18.22M | 18.20M | 18.19M | 18.21M | 18.16M | 18.15M | 18.12M | 18.10M | 18.10M | 18.25M |
| Weighted Avg Shares Out (Dil) | 18.30M | 18.28M | 18.25M | 18.24M | 18.21M | 18.21M | 18.16M | 18.19M | 18.13M | 18.10M | 18.10M | 18.25M |
Source: https://incomestatements.info
Category: Stock Reports